Company: SWKH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050155
Chunk: 87

Company: SWK Holdings Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 87
---
13.3%205 599 eTon Pharmaceuticals, Inc.First lien12/17/2730,000 29,644 11.8%1,156 3,391 Journey Medical CorporationFirst lien12/27/2725,000 25,213 12.8%925 2,742 MedMinder Systems, Inc.First lien08/18/2822,500 22,987 12.3%814 2,406 MolecuLight, Inc.(7)First lien12/29/27— — 12.8%— 27 Nicoya Lifesciences, Inc.First lien11/30/268,500 8,846 12.8%390 954 NeoLight, LLCFirst lien05/15/275,553 5,923 13.5%224 681 Shield Therapeutics, PlcFirst lien09/28/2820,000 20,033 14.3%865 2,533 SKNVFirst lien11/15/2815,997 16,409 14.0%505 1,497 Triple RingFirst lien12/06/288,000 8,049 12.0%287 847 ImpediMedFirst lien02/05/3015,000 14,594 13.8%572 1,198 

Gain (Loss) RecognizedMarketable InvestmentsNumber of SharesFunded AmountGAAP BalanceQ3 2025Year-to-DateAOTI Common Stock (5)402,634 N/A230 (191)(276)Elutia, Inc (8)50,000 N/A$45 $(55)$(38)

29

Privately Held SharesNumber of SharesEpica International, Inc25,000 Sincerus Pharmaceuticals, Inc26,575 MolecuLight, Inc250,000 

Change in Fair Value Warrants to Purchase StockNumber of SharesExercise Price per ShareGAAP BalanceQ3 2025Year-to-Date4Web, Inc. TBD $— $— $— $— ImpediMed Tranche 112,491,870 $0.05 180 29 (131)ImpediMed Tranche 26,245,935 $0.05 90 (88)(88)Aziyo Biologics, Inc. Tranche